Validation of a New Shortness of Breath With Daily Activities Questionnaire in Patients With Chronic Obstructive Pulmonary Disease

Completed · Phase 4 · Has a placebo group

Conditions studied: Pulmonary Disease, Chronic Obstructive

In brief

The purpose of this study is to evaluate a new questionnaire to capture the patient experience of COPD. The information collected will be used to validate the Shortness of Breath with Daily Activities Questionnaire.

Key facts

Study ID

NCT00984659

Run by

GlaxoSmithKline

People needed

366

Starts

2009-10-29

Expected to finish

2010-07-01

Last updated by the study team

2018-08-29

Who can join

Age: 40 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults ≥ 40 years of age
• Established clinical history of COPD by ATS/ERS definition
• Former or current smoker > 10 pack years
• Evidence of dyspnea

You may not qualify if…

• Has a respiratory disorder other than COPD
• Cancer not in complete clinical remission
• Clinically significant cardiovascular, neurological, psychiatric, renal, gastro-intestinal, immunological, endocrine, or hematological abnormalities that are uncontrolled

Where it is running

• GSK Investigational Site — Jasper, Alabama, United States
• GSK Investigational Site — Mobile, Alabama, United States
• GSK Investigational Site — Los Angeles, California, United States
• GSK Investigational Site — Riverside, California, United States
• GSK Investigational Site — Wheat Ridge, Colorado, United States
• GSK Investigational Site — Stamford, Connecticut, United States
• GSK Investigational Site — Tamarac, Florida, United States
• GSK Investigational Site — Decatur, Georgia, United States
• GSK Investigational Site — Lawrenceville, Georgia, United States
• GSK Investigational Site — Evansville, Indiana, United States
• GSK Investigational Site — Evansville, Indiana, United States
• GSK Investigational Site — South Bend, Indiana, United States
• GSK Investigational Site — Madisonville, Kentucky, United States
• GSK Investigational Site — New Orleans, Louisiana, United States
• GSK Investigational Site — Sunset, Louisiana, United States
• GSK Investigational Site — St Louis, Missouri, United States
• GSK Investigational Site — Summit, New Jersey, United States
• GSK Investigational Site — Charlotte, North Carolina, United States
• GSK Investigational Site — Elizabeth City, North Carolina, United States
• GSK Investigational Site — Canton, Ohio, United States
• GSK Investigational Site — Cincinnati, Ohio, United States
• GSK Investigational Site — Lake Oswego, Oregon, United States
• GSK Investigational Site — Portland, Oregon, United States
• GSK Investigational Site — Erie, Pennsylvania, United States
• GSK Investigational Site — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.